olbetam capsule 250mg milligram
farmitalia carlo erba ltd - acipimox - capsule - 250mg milligram
acipicap 10
zydus cnd - acipimox - 250mg - 10
pimorex 10 cap
cdc - acipimox - cap - 250mg - 10
simvastatin 80 mg film-coated tablets
mcdermott laboratories ltd., t/a gerard laboratories - simvastatin - film-coated tablet - 80 milligram(s) - hmg coa reductase inhibitors; simvastatin
simvastatin 20 mg film-coated tablets
mcdermott laboratories ltd., t/a gerard laboratories - simvastatin - film-coated tablet - 20 milligram(s) - hmg coa reductase inhibitors; simvastatin
simvastatin 40 mg film-coated tablets
mcdermott laboratories ltd., t/a gerard laboratories - simvastatin - film-coated tablet - 40 milligram(s) - hmg coa reductase inhibitors; simvastatin
simvastatin 10 mg film-coated tablets
mcdermott laboratories ltd., t/a gerard laboratories - simvastatin - film-coated tablet - 10 milligram(s) - hmg coa reductase inhibitors; simvastatin
ezetimibe/simvastatin 10 mg/40 mg tablets
mcdermott laboratories ltd., t/a gerard laboratories - ezetimibe; simvastatin - tablet - 10 mg/40 milligram(s) - hmg coa reductase inhibitors in combination with other lipid modifying agents; simvastatin and ezetimibe - reductase inhibitors in combination with other lipid modifying agents - it is indicated as adjunctive therapy to diet for use in patients with primary (heterozygous familiar and non-familiar) hypercholesterolaemia or mixed hyperlipidaemia, and in patient with hofh
ezetimibe/simvastatin 10mg/20mg tablets
mcdermott laboratories ltd., t/a gerard laboratories - ezetimibe; simvastatin - tablet - 10mg/20 milligram(s) - hmg coa reductase inhibitors in combination with other lipid modifying agents; simvastatin and ezetimibe - reductase inhibitors in combination with other lipid modifying agents - it is indicated as adjunctive therapy to diet for use in patients with primary (heterozygous familiar and non-familiar) hypercholesterolaemia or mixed hyperlipidaemia, and in patient with hofh
ezetimibe/simvastatin 10mg/80mg tablets
mcdermott laboratories ltd., t/a gerard laboratories - ezetimibe; simvastatin - tablet - 10mg/80 milligram(s) - hmg coa reductase inhibitors in combination with other lipid modifying agents; simvastatin and ezetimibe - reductase inhibitors in combination with other lipid modifying agents - it is indicated as adjunctive therapy to diet for use in patients with primary (heterozygous familiar and non-familiar) hypercholesterolaemia or mixed hyperlipidaemia, and in patient with hofh